Chemoinformaics analysis of 4,9-Dihydroxy-Alpha-Lapachone
| Molecular Weight | 274.272 | nRot | 0 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 17 |
| Exact Molecular Weight | 274.084 | nRing | 3 |
| Solubility: LogS | -3.981 | nHRing | 1 |
| Solubility: LogP | 3.661 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 38.3951 |
| nHD | 2 | BPOL | 17.5169 |
| QED | 0.643 |
| Synth | 2.804 |
| Natural Product Likeliness | 1.619 |
| NR-PPAR-gamma | 0.967 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.045 |
| Pgp-sub | 0 |
| HIA | 0.026 |
| CACO-2 | -4.9 |
| MDCK | 0.0000225 |
| BBB | 0.016 |
| PPB | 0.981284 |
| VDSS | 0.56 |
| FU | 0.0398115 |
| CYP1A2-inh | 0.917 |
| CYP1A2-sub | 0.508 |
| CYP2c19-inh | 0.246 |
| CYP2c19-sub | 0.089 |
| CYP2c9-inh | 0.742 |
| CYP2c9-sub | 0.796 |
| CYP2d6-inh | 0.634 |
| CYP2d6-sub | 0.247 |
| CYP3a4-inh | 0.251 |
| CYP3a4-sub | 0.148 |
| CL | 5.691 |
| T12 | 0.516 |
| hERG | 0.004 |
| Ames | 0.563 |
| ROA | 0.255 |
| SkinSen | 0.888 |
| Carcinogencity | 0.551 |
| EI | 0.785 |
| Respiratory | 0.238 |
| NR-Aromatase | 0.097 |
| Antiviral | Yes |
| Prediction | 0.71959 |